Alpine Global Management’s Avidity Biosciences RNAM Stock Holding History

Alpine Global Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-40,000	Closed	-$2.89M	–	390
2025 Q4	$2.89M	Buy	+40,000	New	+$2.58M	0.62%	36
2024 Q3	–	Sell	-15,363	Closed	-$628K	–	416
2024 Q2	$628K	Buy	+15,363	New	+$441K	0.11%	155

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Alpine Global Management's RNAM Position: Q1 2026 in Review

Alpine Global Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 40,000 shares — an estimated $2.89M sold.

Alpine Global Management first reported a position in RNAM in Q2 2024 and held it in 2 quarters. The position peaked at $2.89M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Alpine Global Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Alpine Global Management sold 40,000 Avidity Biosciences shares in Q1 2026, an estimated $2.89M.
Alpine Global Management first reported a position in Avidity Biosciences in Q2 2024 and held it in 2 quarters.
Alpine Global Management's Avidity Biosciences position peaked at $2.89M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Alpine Global Management's 13F filing for Q1 2026, filed 15 May 2026.